Related Experiment Video
Updated: May 24, 2026
06:46
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Differing clinical features in Aboriginal vs. non-Aboriginal children presenting with type 2 diabetes
Shazhan Amed1, Jill K Hamilton, Elizabeth A C Sellers
1Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
Pediatric Diabetes
|February 29, 2012
Summary
Childhood type 2 diabetes (T2D) presents differently across ethnic groups. Aboriginal children with T2D were younger and had fewer comorbidities than Caucasian children, with regional variations noted in Canada.
Area of Science:
- Pediatrics
- Endocrinology
- Public Health
Background:
- Childhood type 2 diabetes (T2D) incidence is rising globally.
- T2D presentation and progression can vary significantly among diverse pediatric populations.
- Understanding these differences is crucial for effective management and public health strategies.
Purpose of the Study:
- To compare the clinical characteristics of T2D at diagnosis among Aboriginal, Caucasian, and other high-risk ethnic groups of children in Canada.
- To investigate variations in T2D presentation within distinct Aboriginal populations across Canada.
Main Methods:
- Retrospective observational study utilizing Canadian childhood T2D surveillance data (n=227).
- Descriptive statistics were employed to compare clinical features at diagnosis across ethnic groups: Aboriginal (n=100), Caucasian (n=57), and other high-risk (n=64).
- Specific comparisons were made between Aboriginal children from central Canada (n=74) and other Canadian regions (n=26).
Main Results:
- Aboriginal children were diagnosed at a younger age, with lower obesity rates, and less frequent polycystic ovarian syndrome and dyslipidemia compared to Caucasian and other high-risk groups (p < 0.05).
- No significant differences in age, BMI z-score, family history, or acanthosis nigricans were found between central Canadian Aboriginal children and those from other regions.
- Central Canadian Aboriginal children exhibited lower hemoglobin A1c levels and reduced likelihood of dyslipidemia (p < 0.05).
Conclusions:
- Significant variations exist in the clinical presentation and comorbidity rates of newly diagnosed childhood T2D across Caucasian, Aboriginal, and other high-risk ethnic groups.
- Distinct Aboriginal populations in Canada demonstrate differing T2D characteristics, highlighting the need for geographically tailored approaches.
- Further research is warranted to elucidate the specific genetic and environmental factors underlying these observed disparities.
Related Concept Videos
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...